Publications
Light-activated RNA interference in human embryonic stem cells. Biomaterials. 63:70-9.
.
2015. Light-Patterned RNA Interference of 3D-Cultured Human Embryonic Stem Cells. Adv Mater. 28(48):10732-10737.
.
2016. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells. 28(11):1981-91.
.
2010. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell. 7(6):671-81.
.
2010. Molecular cloning and amplification of the adenylate cyclase gene. Proceedings of the National Academy of Sciences. 78(8):4684-8.
.
1981. MUC1* mediates the growth of human pluripotent stem cells. PLoS One. 3(10):e3312.
.
2008. Nerve growth factor gene expression in the developing rat brain. Science. 234(4774):352-5.
.
1986. A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Research. 48(4):186-91.
.
2012. Novel roles for integrins in the nervous system. Molecular Cell Biology Research Communications. 3:1–7.
.
2000. One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.. Transl Vis Sci Technol. 10(10):13.
.
2021. Osteopontin is Expressed in Developing Mouse Optic Tract and Supports Axon Extension of Retinal Ganglion Cells. Investigative Ophtalmology & Visual Science. 45:5371.
.
2004. Osteopontin is Expressed in Developing Mouse Retina and Supports Integrin-Dependent Neurite Outgrowth. Investigative Ophtalmology & Visual Science. 43:2698.
.
2002. Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 47(10):4435-43.
.
2006. Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies.. Progress in Retinal and Eye Research.
.
2018. Pluripotent human stem cells for the treatment of retinal disease. Journal of Cellular Physiology. 227(2):457-66.
.
2012. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration. Journal of Ocular Pharmacology & Therapeutics.
.
2016. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 4(12):e8152.
.
2009. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Translational Medicine. 2(5):384-93.
.
2013. Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells. J Vis Exp. (128)
.
2017. Regenerating Perfection. J Ocul Pharmacol Ther. 32(5):237.
.
2016. Regulation of nerve growth factor mRNA levels in developing rat heart ventricle is not altered by sympathectomy. Developmental Biology. 134(1):30-7.
.
1989. Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins. Stem Cells Translational Medicine. 3(12):1526-34.
.
2014. Restoring Vision to the Blind: The Lasker/IRRF Initiative for Innovation in Vision Science.. Transl Vis Sci Technol. 3(7):1.
.
2014. ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium. Stem Cells Translational Medicine. 3(9):1066-78.
.
2014. .
2016.